The TRAIL apoptotic pathway in cancer onset, progression and therapy
RW Johnstone, AJ Frew, MJ Smyth - Nature Reviews Cancer, 2008 - nature.com
Triggering of tumour cell apoptosis is the foundation of many cancer therapies. Death
receptors of the tumour necrosis factor (TNF) superfamily have been largely characterized …
receptors of the tumour necrosis factor (TNF) superfamily have been largely characterized …
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
R Schickel, B Boyerinas, SM Park, ME Peter - Oncogene, 2008 - nature.com
Micro (mi) RNAs are small, highly conserved noncoding RNAs that control gene expression
post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein …
post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein …
[PDF][PDF] Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment
B Blechacz, GJ Gores - Hepatology, 2008 - Wiley Online Library
Cholangiocarcinoma (CCA) is an epithelial can-cer originating from the bile ducts with
features of cholangiocyte differentiation. 1 CCA is the second most common primary hepatic …
features of cholangiocyte differentiation. 1 CCA is the second most common primary hepatic …
Apoptotic signaling by c-MYC
B Hoffman, DA Liebermann - Oncogene, 2008 - nature.com
Abstract c-MYC has a pivotal function in growth control, differentiation and apoptosis, and its
abnormal expression is associated with many tumors. Overexpression of c-MYC sensitizes …
abnormal expression is associated with many tumors. Overexpression of c-MYC sensitizes …
Saga of Mcl-1: regulation from transcription to degradation
VV Senichkin, AY Streletskaia, AS Gorbunova… - Cell Death & …, 2020 - nature.com
The members of the Bcl-2 family are the central regulators of various cell death modalities.
Some of these proteins contribute to apoptosis, while others counteract this type of …
Some of these proteins contribute to apoptosis, while others counteract this type of …
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
ML Stewart, E Fire, AE Keating, LD Walensky - Nature chemical biology, 2010 - nature.com
The development of selective inhibitors for discrete anti-apoptotic BCL-2 family proteins
implicated in pathologic cell survival remains a formidable but pressing challenge. Such …
implicated in pathologic cell survival remains a formidable but pressing challenge. Such …
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
A Ashkenazi - Nature reviews Drug discovery, 2008 - nature.com
Each day, the human body eliminates billions of unwanted cells by apoptotic suicide.
Apoptosis provides an important barrier against cancer; however, specific mutations enable …
Apoptosis provides an important barrier against cancer; however, specific mutations enable …
Cytokines, inflammation and colon cancer
L Klampfer - Current cancer drug targets, 2011 - ingentaconnect.com
Patients with inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease,
are at increased risk of developing colon cancer, confirming that chronic inflammation …
are at increased risk of developing colon cancer, confirming that chronic inflammation …
Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor–related apoptosis-inducing ligand …
A Ashkenazi, P Holland, SG Eckhardt - Journal of clinical oncology, 2008 - ascopubs.org
Cancer is a leading cause of premature human death and commands considerable
research attention. Apoptosis (type 1 programmed cell death) is critical in maintaining tissue …
research attention. Apoptosis (type 1 programmed cell death) is critical in maintaining tissue …